Aethlon Medical (AEMD) Reports Q2 Loss of $0.29

November 10, 2016 5:05 PM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aethlon Medical (NASDAQ: AEMD) reported Q2 EPS of ($0.29), versus ($0.16) reported last year. Revenue for the quarter came in at $387 thousand, versus $188.4 thousand reported last year.

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment